Kimia Biosciences [KIMIABL] vs Innova Captab [INNOVACAP] Detailed Stock Comparison

Kimia Biosciences Ltd.

BSE
Loading...

Innova Captab Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Kimia Biosciences Ltd. wins in 5 metrics, Innova Captab Ltd. wins in 7 metrics, with 0 ties. Innova Captab Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Kimia Biosciences Ltd. Innova Captab Ltd. Better
P/E Ratio (TTM) N/A 31.20 N/A
Price-to-Book Ratio 15.97 4.05 Innova Captab Ltd.
Debt-to-Equity Ratio 311.45 32.95 Innova Captab Ltd.
PEG Ratio N/A 1.33 N/A
EV/EBITDA 10.88 20.49 Kimia Biosciences Ltd.
Profit Margin (TTM) 7.19% 8.85% Innova Captab Ltd.
Operating Margin (TTM) 18.95% 12.88% Kimia Biosciences Ltd.
EBITDA Margin (TTM) 18.95% 12.88% Kimia Biosciences Ltd.
Return on Equity N/A 13.37% N/A
Return on Assets (TTM) N/A 8.12% N/A
Free Cash Flow (TTM) N/A $-1.09B N/A
Dividend Yield N/A 0.30% N/A
1-Year Return -26.63% -3.19% Innova Captab Ltd.
Price-to-Sales Ratio (TTM) 1.44 2.76 Kimia Biosciences Ltd.
Enterprise Value $2.10B $43.41B Innova Captab Ltd.
EV/Revenue Ratio 1.67 2.90 Kimia Biosciences Ltd.
Gross Profit Margin (TTM) N/A 35.19% N/A
Revenue per Share (TTM) $27 $262 Innova Captab Ltd.
Earnings per Share (Diluted) N/A $23.16 N/A
Beta (Stock Volatility) 0.89 -0.33 Innova Captab Ltd.

Kimia Biosciences Ltd. vs Innova Captab Ltd. Stock Performance Analysis

Loading Price Chart...

KIMIABL
INNOVACAP

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Kimia Biosciences Ltd.0.33%-9.12%-4.82%8.73%13.21%-6.14%
Innova Captab Ltd.1.81%1.28%1.49%32.44%19.52%16.05%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Kimia Biosciences Ltd.-26.63%2.24%-15.80%82.50%82.50%82.50%
Innova Captab Ltd.-3.19%57.07%57.07%57.07%57.07%57.07%

Performance & Financial Health Analysis: Kimia Biosciences Ltd. vs Innova Captab Ltd.

MetricKIMIABLINNOVACAP
Market Information
Market Cap i₹1.81B₹41.43B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i5,891578,151
90 Day Avg. Volume i7,027217,693
Last Close₹33.11₹872.55
52 Week Range₹23.20 - ₹86.85₹622.00 - ₹1,020.70
% from 52W High-61.88%-14.51%
All-Time High₹86.85 (Jul 02, 2025)₹1,260.00 (Jan 06, 2025)
% from All-Time High-61.88%-30.75%
Growth Metrics
Quarterly Revenue Growth0.00%0.42%
Quarterly Earnings Growth0.19%0.23%
Financial Health
Profit Margin (TTM) i0.07%0.09%
Operating Margin (TTM) i0.19%0.13%
Return on Equity (TTM) iN/A0.13%
Debt to Equity (MRQ) i311.4532.95
Cash & Liquidity
Book Value per Share (MRQ)₹2.40₹178.28
Cash per Share (MRQ)₹0.15₹10.22
Operating Cash Flow (TTM) i₹0₹282.88M
Levered Free Cash Flow (TTM) i₹0₹1.28B
Dividends
Last 12-Month Dividend Yield iN/A0.30%
Last 12-Month Dividend iN/A₹2.00

Valuation & Enterprise Metrics Analysis: Kimia Biosciences Ltd. vs Innova Captab Ltd.

MetricKIMIABL (Apr 24, 2026)INNOVACAP (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) iN/A31.20
Forward P/E iN/A21.90
PEG Ratio iN/A1.33
Price to Sales (TTM) i1.442.76
Price to Book (MRQ) i15.974.05
Market Capitalization
Market Capitalization i₹1.81B₹41.43B
Enterprise Value i₹2.10B₹43.41B
Enterprise Value Metrics
Enterprise to Revenue i1.672.90
Enterprise to EBITDA i10.8820.49
Risk & Other Metrics
Beta i0.89-0.33
Book Value per Share (MRQ) i₹2.40₹178.28

Financial Statements Comparison: Kimia Biosciences Ltd. vs Innova Captab Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricKIMIABLINNOVACAP (2025)
Revenue/Sales iN/A12.34B
Cost of Goods Sold iN/A8.38B
COGS % of Revenue i-67.9%
Gross Profit iN/A3.96B
Gross Margin i-32.1%
Research & Development iN/AN/A
Operating Income (EBIT) iN/A1.65B
Operating Margin i-13.4%
EBITDA iN/A2.00B
EBITDA Margin i-16.2%
Pre-Tax Income iN/A1.71B
Pre-Tax Income % of Revenue i-13.9%
Income Tax iN/A427.58M
Income Tax % of Revenue i-3.5%
Net Income (Profit) iN/A1.28B
Profit Margin i-10.4%

Balance Sheet & Liquidity Metrics

MetricKIMIABLINNOVACAP (2025)
Cash & Equivalents iN/A155.19M
Total Current Assets iN/A7.03B
Total Current Assets % of Revenue i-57.0%
Total Current Liabilities iN/A3.53B
Total Current Liabilities % of Revenue i-28.6%
Long-Term Debt iN/A2.45B
Long-Term Debt % of Revenue i-19.8%
Total Shareholders Equity iN/A9.59B
Retained Earnings iN/A4.53B
Retained Earnings % of Revenue i-36.7%
Property, Plant & Equipment iN/A442.93M

Cash Flow Statement Comparison

MetricKIMIABLINNOVACAP (2025)
Operating Cash Flow iN/A282.88M
Operating Cash Flow % of Revenue i-2.3%
Capital Expenditures iN/A-1.72B
Free Cash Flow iN/A-1.09B
FCF Margin i--8.8%
Debt Repayment iN/A-114.03M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricKIMIABLINNOVACAP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i47.31M57.22M
Float Shares i2.55M15.91M
% Held by Insiders i91.00%72.19%
% Held by Institutions i0.00%19.22%
% Held by Public i9.00%8.59%

Dividend Analysis & Yield Comparison: Kimia Biosciences Ltd. vs Innova Captab Ltd.

MetricKIMIABLINNOVACAP
Last 12-Month Dividend iN/A₹2.00
Last 12-Month Dividend Yield iN/A0.30%
3-Year Avg Annual Dividend iN/A₹0.67
3-Year Avg Dividend Yield iN/A0.30%
3-Year Total Dividends iN/A₹2.00
Ex-Dividend DateN/AJan 30, 2026